| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis
|
Villacampa, Guillermo
|
|
|
104 |
C |
p.
|
artikel
|
| 2 |
Chemotherapy in pancreatic ductal adenocarcinoma: When cytoreduction is the aim. A systematic review and meta-analysis
|
Meneses-Medina, Monica I.
|
|
|
104 |
C |
p.
|
artikel
|
| 3 |
Corrigendum to “Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC” [Cancer Treat. Rev. 104 (2022) 102350]
|
Friedlaender, Alex
|
|
|
104 |
C |
p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
104 |
C |
p.
|
artikel
|
| 5 |
Efficacy of targeted therapies for oncogene-driven lung cancer in early single-arm versus late phase randomized clinical trials: A comparative analysis
|
Tan, Aaron C.
|
|
|
104 |
C |
p.
|
artikel
|
| 6 |
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients
|
Macchini, Marina
|
|
|
104 |
C |
p.
|
artikel
|
| 7 |
Global challenges and policy solutions in breast cancer control
|
Trapani, Dario
|
|
|
104 |
C |
p.
|
artikel
|
| 8 |
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis
|
Martini, Alberto
|
|
|
104 |
C |
p.
|
artikel
|
| 9 |
Neuroblastoma survivors at risk for developing subsequent neoplasms: A systematic review
|
Westerveld, Aimée S.R.
|
|
|
104 |
C |
p.
|
artikel
|
| 10 |
PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence
|
Bieńkowski, Michał
|
|
|
104 |
C |
p.
|
artikel
|
| 11 |
Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis
|
Papakonstantinou, Andri
|
|
|
104 |
C |
p.
|
artikel
|
| 12 |
Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC
|
Friedlaender, Alex
|
|
|
104 |
C |
p.
|
artikel
|
| 13 |
Systematic review of fetal and placental metastases among pregnant patients with cancer
|
Khazzaka, Aline
|
|
|
104 |
C |
p.
|
artikel
|
| 14 |
The association between guideline adherence, age and overall survival among women with non-metastatic breast cancer: A systematic review
|
Miller, Katie
|
|
|
104 |
C |
p.
|
artikel
|
| 15 |
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives
|
Patelli, Giorgio
|
|
|
104 |
C |
p.
|
artikel
|
| 16 |
Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology
|
Shah, Shreya M.
|
|
|
104 |
C |
p.
|
artikel
|
| 17 |
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours
|
Crucitta, Stefania
|
|
|
104 |
C |
p.
|
artikel
|
Tijdschrift beschrijving